StockData
INMNasdaqPharmaceutical PreparationsFiscal year ends June 30

InMed Pharmaceuticals Inc.

Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 9, 2026
$1.37+0.05 (+3.44%)

Close on Oct 19, 2026

Market cap
$6.42M
P/E (TTM)
–
Dividend yield
–

InMed Pharmaceuticals Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

InMed Pharmaceuticals does not break out revenue by segment, region or product in the tagged data of its filings for this period type.